(19)
(11) EP 3 876 945 A1

(12)

(43) Date of publication:
15.09.2021 Bulletin 2021/37

(21) Application number: 19881364.4

(22) Date of filing: 16.10.2019
(51) International Patent Classification (IPC): 
A61K 31/575(2006.01)
A61P 1/16(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/575; A61P 1/16
(86) International application number:
PCT/IL2019/051121
(87) International publication number:
WO 2020/095293 (14.05.2020 Gazette 2020/20)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 07.11.2018 US 201816182767

(71) Applicant: Galmed Research and Development Ltd.
6578317 Tel Aviv (IL)

(72) Inventors:
  • HAYARDENY-NISSIMOV, Liat
    6939104 Tel Aviv (IL)
  • GORFINE, Tali
    6494210 Tel Aviv (IL)
  • BAHARAFF, Allen
    6215441 Tel Aviv (IL)
  • MATO DE LA PAZ, Jose M.
    48992 Getxo (ES)

(74) Representative: Pearl Cohen Zedek Latzer Baratz UK LLP 
The Gridiron Building One Pancras Square
London N1C 4AG
London N1C 4AG (GB)

   


(54) TREATMENT AND INHIBITION OF FIBROSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS